Yingxia Ning

Guangzhou, 510120, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Nobiletin attenuates self-renewal in cervical cancer cells and spheres through miR-342-3p upregulation and FOXM1 downregulation.

Nobiletin attenuates self-renewal in cervical cancer cells and spheres through miR-342-3p upregulation and FOXM1 downregulation.

Journal: Molecular and cellular biochemistry

Published: February 09, 2026

Potential Anti-Cancer Drug 6RK73 Suppresses Ovarian Cancer Growth by Inactivating the AKT1/Sp1 Induced c-Myc Signaling Pathway.

Potential Anti-Cancer Drug 6RK73 Suppresses Ovarian Cancer Growth by Inactivating the AKT1/Sp1 Induced c-Myc Signaling Pathway.

Journal: Journal of Cancer

Published: March 10, 2025

Interference with ANXA8 inhibits the malignant progression of ovarian cancer by suppressing the activation of the Wnt/β-catenin signaling pathway via UCHL5.

Interference with ANXA8 inhibits the malignant progression of ovarian cancer by suppressing the activation of the Wnt/β-catenin signaling pathway via UCHL5.

Journal: Aging

Published: January 15, 2024

Retraction Note: Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.

Retraction Note: Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 23, 2023

Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways.

Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways.

Journal: Oncology research

Published: January 02, 2023

A miRNA-205-based model for prediction of the recurrence of endometrioid endometrial cancer.

A miRNA-205-based model for prediction of the recurrence of endometrioid endometrial cancer.

Journal: American journal of translational research

Published: December 07, 2022

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer.

Co-Overexpression of GRK5/ACTC1 Correlates With the Clinical Parameters and Poor Prognosis of Epithelial Ovarian Cancer.

Journal: Frontiers in molecular biosciences

Published: September 29, 2021

The Use of Bionic Prodrugs for the Enhancement of Low Dose Radiotherapy.

The Use of Bionic Prodrugs for the Enhancement of Low Dose Radiotherapy.

Journal: Frontiers in chemistry

Published: May 20, 2021

Correction to: Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.

Correction to: Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 05, 2021

VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.

VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.

Journal: Cancer science

Published: December 29, 2020

High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.

High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer.

Journal: Recent patents on anti-cancer drug discovery

Published: September 03, 2020

Sevoflurane alleviates hepatic ischaemia/reperfusion injury by up-regulating miR-96 and down-regulating FOXO4.

Sevoflurane alleviates hepatic ischaemia/reperfusion injury by up-regulating miR-96 and down-regulating FOXO4.

Journal: Journal of cellular and molecular medicine

Published: April 28, 2020

Showing 1-12 of 24

Last Updated: 09/26/2026